Clinical Trial: Oral methylprednisolone or Intravenous methylprednisolone “OMEGA study” - National Multiple Sclerosis Society

Skip to navigation Skip to content

Clinical Trial: Oral methylprednisolone or Intravenous methylprednisolone “OMEGA study”

Share

Details
Type of MS: PRMS|RRMS|SPMS
Treatment mode of action: To affect immune function during an acute MS attack
Number of Subjects: 120
Medication: methylprednisolone or Intravenous methylprednisolone
Location: NY
Contact Information
Michele J. Weber, MS, CCRC
212-241-4264
Michele.weber@mssm.edu

Funding:

National Multiple Sclerosis Society

Description

Randomized, double-blind study to compare oral versus IV use of steroids during an acute exacerbation of relapsing forms of MS.

Share